NYMX

Nymox Pharmaceutical Corp
NYMX

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

NYMX was delisted on the 6th of July, 2023.

Back to rankings

41 hedge funds and large institutions have $14.3M invested in Nymox Pharmaceutical Corp in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 21 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

89% less call options, than puts

Call options by funds: $201K | Put options by funds: $1.87M

Holders
41
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$201K
Puts
$1.87M
Net Calls
Net Calls Change

Top Buyers

1
+$353K
2
+$184K
3
+$151K
4
Deutsche Bank
Deutsche Bank
Germany
+$143K
5
Morgan Stanley
Morgan Stanley
New York
+$82.5K

Top Sellers

1
-$134K
2
-$76K
3
-$60K
4
Goldman Sachs
Goldman Sachs
New York
-$53K
5
NPC
National Planning Corporation
California
-$42K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$40K
27
$34K
28
$32K
29
$30K
30
$26.6K
31
$26K
32
$25K
33
$24K
34
$22K
35
$22K
36
$19K
37
$14K
38
$14K
39
$6K
40
$4K
41
$3K
42
–
43
–
44
–
45
–
46
–
47
–
1
2